Table 2 Univariate analysis of survival-related factors in serous ovarian cancer
From: Age is associated with prognosis in serous ovarian carcinoma
Variable | Progression-free survival (OR, 95% CI)* | Overall survival (OR, 95% CI)* | ||
|---|---|---|---|---|
Age | 1.01 | 1.00–1.02 | 1.01 | 1.00–1.02 |
FIGO stage | ||||
 I | 1.00 | (reference) | 1.00 | (reference) |
 II | 2.25 | 0.85–5.12 | 1.85 | 0.70–4.84 |
 III | 2.84 | 1.43–5.95 | 3.51 | 1.67–7.58 |
 IV | 3.28 | 1.52–6.87 | 4.87 | 2.25–8.83 |
Grade | 1.87 | 1.25–2.90 | 2.30 | 1.68–3.81 |
Ascites# | ||||
  < 500 mL | 1.00 | (reference) | 1.00 | (reference) |
  ≥ 500 mL | 1.75 | 0.79–6.23 | 1.15 | 0.70–5.97 |
Surgery outcome | ||||
 Optimal | 1.00 | (reference) | 1.00 | (reference) |
 Suboptimal | 2.97 | 1.48–7.09 | 3.54 | 2.10–5.08 |
NAC | ||||
 Yes | 1.00 | (reference) | 1.00 | (reference) |
 No | 1.15 | 0.74–3.28 | 1.10 | 0.70–4.27 |
Baseline CA-125†| 1.01 | 1.00–1.02 | 1.01 | 1.00–1.02 |